InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Crouse Steven C.. Director active across 2 companies, notably BIO-TECHNE Corp. In total, 8 filings have been published. Activity tracked since 1 May 2026. The latest transaction was disclosed on 15 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Crouse Steven C. is a declarant linked to BIO-TECHNE Corp, where he is President - Diag & Spatial Bi, and to OmniAb, Inc., where he is Director. His 5 filings on record run from 2026-05-05 to 2026-06-18, and the transactions observed in this recent sample relate to option exercises, with published amounts of EUR 14588.68404867688 and EUR 9256.0259326732.